AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ROSUVASTATIN;EZETIMIBE
9 registrations across 3 African markets— 9 active
Markets with ROSUVASTATIN;EZETIMIBE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ROSTATIN Z 10/20 CAPSULE; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Mar 2031 |
| ROSTATIN Z 10/10 CAPSULE; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Mar 2031 |
| Rovista EZ Tablets 20mg+10mg Film-Coated Tablet | 🇰🇪Kenya | Getz Pharma (Pvt.) Limited | active | Mar 2029 |
| Rovista EZ Tablets 10mg+10mg Film-Coated Tablet | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Mar 2029 |
| Rovista EZ Tablets 5mg+10mg Film-Coated Tablet | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Mar 2029 |
| ROSUZET 20 mg/10 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Nov 2027 |
| ROSUZET 40 mg/10 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Nov 2027 |
| ROSUZET 5 mg/10 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Nov 2027 |
| ROSUZET 10 mg/10 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Nov 2027 |
ROSUVASTATIN;EZETIMIBE in Africa — Regulatory Overview
ROSUVASTATIN;EZETIMIBE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.